Early research (Phase 1)Study completedNCT03583346
What this trial is testing
Multiple Ascending Doses (MAD) of Anti-A Disintegrin and Metalloproteinase With Thrombospondin Motifs-5 (Anti-ADAMTS-5) Nanobody in Participants With Knee Osteoarthritis (OA)
Who this might be right for
Osteoarthritis, Knee
Merck KGaA, Darmstadt, Germany 32